These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27014840)

  • 1. The relevance of coagulation factor X protection of adenoviruses in human sera.
    Duffy MR; Doszpoly A; Turner G; Nicklin SA; Baker AH
    Gene Ther; 2016 Jul; 23(7):592-6. PubMed ID: 27014840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
    Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
    PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.
    Xu Z; Qiu Q; Tian J; Smith JS; Conenello GM; Morita T; Byrnes AP
    Nat Med; 2013 Apr; 19(4):452-7. PubMed ID: 23524342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
    Harmon AW; Moitra R; Xu Z; Byrnes AP
    PLoS One; 2018; 13(2):e0192353. PubMed ID: 29401488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer.
    Parker AL; Waddington SN; Buckley SM; Custers J; Havenga MJ; van Rooijen N; Goudsmit J; McVey JH; Nicklin SA; Baker AH
    J Virol; 2009 Jan; 83(1):479-83. PubMed ID: 18945780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
    Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
    Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus).
    Alba R; Bradshaw AC; Mestre-Francés N; Verdier JM; Henaff D; Baker AH
    Gene Ther; 2012 Jan; 19(1):109-13. PubMed ID: 21677690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
    Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
    Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction
    Lopez-Gordo E; Doszpoly A; Duffy MR; Coughlan L; Bradshaw AC; White KM; Denby L; Nicklin SA; Baker AH
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.
    Bradshaw AC; Parker AL; Duffy MR; Coughlan L; van Rooijen N; Kähäri VM; Nicklin SA; Baker AH
    PLoS Pathog; 2010 Oct; 6(10):e1001142. PubMed ID: 20949078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity.
    Krutzke L; Prill JM; Engler T; Schmidt CQ; Xu Z; Byrnes AP; Simmet T; Kreppel F
    J Control Release; 2016 Aug; 235():379-392. PubMed ID: 27302248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Model for Factor X Inhibition of IgM and Complement-Mediated Neutralization of Adenovirus.
    Wagner N; Shayakhmetov DM; Stewart PL
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel small molecule inhibitors of adenovirus gene transfer using a high throughput screening approach.
    Duffy MR; Parker AL; Kalkman ER; White K; Kovalskyy D; Kelly SM; Baker AH
    J Control Release; 2013 Aug; 170(1):132-40. PubMed ID: 23702233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-Antibody Complexes Contributed to Lethal Systemic Inflammation in a Gene Therapy Trial.
    Somanathan S; Calcedo R; Wilson JM
    Mol Ther; 2020 Mar; 28(3):784-793. PubMed ID: 32035027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
    Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
    Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Coagulation Factor X Exerts Differential Effects on Adenovirus Entry into Human Lymphocytes.
    Findlay JS; Cook GP; Blair GE
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29301346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse adenovirus type 1 and human adenovirus type 5 differ in endothelial cell tropism and liver targeting.
    Lenaerts L; McVey JH; Baker AH; Denby L; Nicklin S; Verbeken E; Naesens L
    J Gene Med; 2009 Feb; 11(2):119-27. PubMed ID: 19065608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery.
    Lopez-Gordo E; Denby L; Nicklin SA; Baker AH
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1795-813. PubMed ID: 25036189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
    Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
    J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.